{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:42:39Z","timestamp":1790714559445,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T00:00:00Z","timestamp":1646956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.yrtph.2022.105154","type":"journal-article","created":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T13:03:08Z","timestamp":1646744588000},"page":"105154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Isoflucypram: Combining in vivo and NAMs data in a weight of evidence approach to demonstrate the human non-relevance of the mode of action leading to the subtle thyroid effects observed in the rat"],"prefix":"10.1016","volume":"131","author":[{"given":"H.","family":"Tinwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Bars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.yrtph.2022.105154_bib1","first-page":"5311","article-title":"Guidance for the identification of endocrine disruptors in the context of Regulations (EU) No 528\/2012 and (EC) No 1107\/2009","volume":"16","author":"Andersson","year":"2018","journal-title":"EFSA J."},{"key":"10.1016\/j.yrtph.2022.105154_bib2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.yrtph.2018.07.025","article-title":"Human relevance of follicular thyroid tumors in rodents caused by non-genotoxic substances","volume":"98","author":"Bartsch","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"5","key":"10.1016\/j.yrtph.2022.105154_bib3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1089\/thy.2008.0341","article-title":"Delayed neurobehavioral development in children born to pregnant women with mild hypothyroxinemia during the first month of gestation: the importance of early iodine supplementation","volume":"19","author":"Berbel","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.yrtph.2022.105154_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2021.104884","article-title":"Metribuzin-induced non-adverse liver changes result in rodent-specific non-adverse thyroid effects via uridine 5\u2019-diphospho-glucoronosyltransferase (UDPGT, UGT) modulation","volume":"122","author":"Bomann","year":"2021","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2022.105154_bib5","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1016\/0006-2952(85)90355-7","article-title":"Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450","volume":"34","author":"Burke","year":"1985","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.yrtph.2022.105154_bib6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1006\/taap.2000.9019","article-title":"Dietary genistein inactivates rat thyroid peroxidase in vivo without an apparent hypothyroid effect","volume":"168","author":"Chang","year":"2000","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2022.105154_bib7","series-title":"Commission Regulation (EU) 2018\/605 of 19 April 2018 Amending Annex II to Regulation (EC) No 1107\/2009 by Setting Out Scientific Criteria for the Determination of Endocrine Disrupting Properties","year":"2018"},{"issue":"2","key":"10.1016\/j.yrtph.2022.105154_bib8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.etap.2007.04.008","article-title":"Short-term in vivo exposure to the water contaminant triclosan: evidence for disruption of thyroxine","volume":"24","author":"Crofton","year":"2007","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2022.105154_bib9","article-title":"In vitro evaluation of major in vivo drug metabolic pathways using primary human hepatocytes and HepaRG cells in suspension and a dynamic three-dimensional bioreactor system","author":"Darnell","year":"2012","journal-title":"J. PET"},{"key":"10.1016\/j.yrtph.2022.105154_bib10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/10408440600975242","article-title":"Thiazopyr and thyroid disruption: case study within the context of the 2006 IPCS Human Relevance Framework for analysis of a cancer mode of action","volume":"36","author":"Dellarco","year":"2006","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2022.105154_bib11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/00401706.1964.10490181","article-title":"Multiple comparisons using rank sums","volume":"6","author":"Dunn","year":"1964","journal-title":"Technometrics"},{"key":"10.1016\/j.yrtph.2022.105154_bib12","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1080\/01621459.1955.10501294","article-title":"A multiple comparison procedure for comparing several treatments with a control","volume":"50","author":"Dunnett","year":"1955","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.yrtph.2022.105154_bib13","series-title":"Guidance to Regulation (EC) No 1272\/2008 on Classification, Labelling and Packaging (CLP) of Substances and Mixtures. Version 5.0","year":"2017"},{"key":"10.1016\/j.yrtph.2022.105154_bib14","first-page":"4","article-title":"Data requirments for active substances, in accordance with Regulation (EC) No 1107\/2009 of the European Parliament and of the Council concerning the placement of plant protection products on the market","volume":"3","year":"2013","journal-title":"Off. J. European Union"},{"key":"10.1016\/j.yrtph.2022.105154_bib15","series-title":"FRAC Code List \u00a9*2021: Fungicides Sorted by Mode of Action (Including FRAC Code Numbering)","year":"2021"},{"key":"10.1016\/j.yrtph.2022.105154_bib16","doi-asserted-by":"crossref","DOI":"10.1007\/s00204-020-02961-6","article-title":"A review of species differences in the control of, and response to, chemical-induced thyroid hormone perturbations leading to thyroid cancer","author":"Foster","year":"2021","journal-title":"Arch. Toxicol."},{"issue":"6","key":"10.1016\/j.yrtph.2022.105154_bib17","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1289\/ehp.11089","article-title":"Developmental exposure to perchlorate alters synaptic transmission in hippocampus of the adult rat","volume":"116","author":"Gilbert","year":"2008","journal-title":"Environ. Health Perspect."},{"issue":"8","key":"10.1016\/j.yrtph.2022.105154_bib18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJM199908193410801","article-title":"Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child","volume":"341","author":"Haddow","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yrtph.2022.105154_bib19","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1042\/bj1290605","article-title":"Assay and properties of dititonin-activated bilirubin uridine diphosphate glucoronyltransferase from rat liver","volume":"129","author":"Heirwegh","year":"1972","journal-title":"Biochem. J."},{"key":"10.1016\/j.yrtph.2022.105154_bib20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/taap.1999.8752","article-title":"Effects of microsomal enzyme inducers on thyroid-follicular cell proliferation, hyperplasia, and hypertrophy","volume":"160","author":"Hood","year":"1999","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2022.105154_bib21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.reprotox.2003.10.012","article-title":"Evaluation of the rodent Hershberger assay using three reference endocrine disrupters (androgen and antiandrogens)","volume":"18","author":"Kennel","year":"2004","journal-title":"Reprod. Toxicol."},{"issue":"1","key":"10.1016\/j.yrtph.2022.105154_bib22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1542\/peds.2005-0227","article-title":"Neonatal effects of maternal hypothyroxinemia during early pregnancy","volume":"117","author":"Kooistra","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.yrtph.2022.105154_bib23","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/01621459.1952.10483441","article-title":"Use of ranks in one criterion variance analysis","volume":"47","author":"Kruskal","year":"1952","journal-title":"J. Aer. Statist. Ass."},{"key":"10.1016\/j.yrtph.2022.105154_bib24","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1039\/c8tx00008e","article-title":"Human relevance of rodent liver tumour formation by constitutive androstane receptor (CAR) activators","volume":"7","author":"Lake","year":"2018","journal-title":"Toxicology Res."},{"key":"10.1016\/j.yrtph.2022.105154_bib25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/toxsci\/kfr099","article-title":"A molecular and phenotypic integrative apporacj to identify a no effect dose level for antiandrogen-induced testicular toxicity","volume":"122","author":"Ludwig","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2022.105154_bib26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1214\/aoms\/1177730491","article-title":"On a test of whether one of two random variables is stochastically larger than the other","volume":"18","author":"Mann","year":"1947","journal-title":"Ann. Math. Stat."},{"key":"10.1016\/j.yrtph.2022.105154_bib27","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1177\/0192623310373778","article-title":"Hepatic enzyme induction","volume":"38","author":"Maronpot","year":"2010","journal-title":"Histopathology. Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2022.105154_bib29","doi-asserted-by":"crossref","DOI":"10.1080\/713608373","article-title":"A framework for human relevance analysis of information on carcinogenic modes of action","volume":"33","author":"Meek","year":"2003","journal-title":"Crit. Rev. Toxicol."},{"issue":"11","key":"10.1016\/j.yrtph.2022.105154_bib30","first-page":"3975","article-title":"Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia?","volume":"85","author":"Morreale de Escobar","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.yrtph.2022.105154_bib31","doi-asserted-by":"crossref","DOI":"10.1289\/EHP5297","article-title":"Evaluating chemicals for thyroid disruption: opportunities and challenges with in vitro testing and adverse outcome pathway approaches","volume":"127","author":"Noyes","year":"2019","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.yrtph.2022.105154_bib32","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1021\/tx400310w","article-title":"Development of a thyroperoxidase inhibition assay for high-throughput screening","volume":"27","author":"Paul","year":"2014","journal-title":"Chem. Res. Toxicol."},{"issue":"1\u20132","key":"10.1016\/j.yrtph.2022.105154_bib33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tox.2012.05.023","article-title":"Developmental triclosan exposure decreases maternal, fetal, and early neonatal thyroxine: a dynamic and kinetic evaluation of a putative mode-of-action","volume":"300","author":"Paul","year":"2012","journal-title":"Toxicology"},{"issue":"2","key":"10.1016\/j.yrtph.2022.105154_bib34","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/toxsci\/kfp271","article-title":"Short-term exposure to triclosan decreases thyroxine in vivo via upregulation of hepatic catabolism in Young Long-Evans rats","volume":"113","author":"Paul","year":"2010","journal-title":"Toxicol. Sci."},{"issue":"3","key":"10.1016\/j.yrtph.2022.105154_bib35","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1365-2265.2003.01822.x","article-title":"Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study","volume":"59","author":"Pop","year":"2003","journal-title":"Clin. Endocrinol."},{"issue":"2","key":"10.1016\/j.yrtph.2022.105154_bib36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1365-2265.1999.00639.x","article-title":"Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy","volume":"50","author":"Pop","year":"1999","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.yrtph.2022.105154_bib37","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1007\/s00216-016-9740-4","article-title":"Metabolic fate of desomorphine elucidated using rat urine, pooled human liver preparations, and human hepatocyte cultures as well as its detectability using standard urine screening approaches","volume":"408","author":"Richter","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.yrtph.2022.105154_bib38","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.yrtph.2014.10.003","article-title":"Thyroid tumor formation in the male mouse induced by fluopyram is mediated by activation of hepatic CAR\/PXR nuclear receptors","volume":"70","author":"Rouqui\u00e9","year":"2014","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2022.105154_bib39","series-title":"T-test and Modified T-Test. Statistical Methods","author":"Snedecor","year":"1989"},{"key":"10.1016\/j.yrtph.2022.105154_bib40","series-title":"Bartlett Test. Biometry","first-page":"403","author":"Sokal","year":"1981"},{"key":"10.1016\/j.yrtph.2022.105154_bib41","series-title":"Transformations (Log Transformation)","first-page":"417","author":"Sokal","year":"1981"},{"key":"10.1016\/j.yrtph.2022.105154_bib42","series-title":"F Test. Biometry","first-page":"189","author":"Sokal","year":"1981"},{"key":"10.1016\/j.yrtph.2022.105154_bib43","series-title":"Levene Test. Biometry","first-page":"403","author":"Sokal","year":"1981"},{"key":"10.1016\/j.yrtph.2022.105154_bib44","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.yrtph.2014.09.011","article-title":"Liver tumor formation in female rat induced by fluopyram is mediated by CAR\/PXR nucelar receptor activation","volume":"70","author":"Tinwell","year":"2014","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2022.105154_bib45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ab.2009.08.038","article-title":"A noradioactive iodide uptake assay for sodium iodide sumporter function","volume":"396","author":"Waltz","year":"2010","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.yrtph.2022.105154_bib46","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1248\/bpb.b17-00913","article-title":"Comparison of drug metabolism and its related hepatotoxic effects in HepaRG, cryopreserved human hepatocytes, and HepG2 cell cultures","volume":"41","author":"Yokoyama","year":"2018","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.yrtph.2022.105154_bib47","first-page":"443","article-title":"The effects of lipid protein interactions on the kinetic parameters of microsomal UDP-glucuronosyltransferase","volume":"2","author":"Zakim","year":"1976"},{"issue":"1","key":"10.1016\/j.yrtph.2022.105154_bib48","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/toxsci\/61.1.76","article-title":"Effects of short term in vivo exposure to polybrominated diphenyl ethers on thyroid hormones and hepatic enzyme activities in weanling rats","volume":"61","author":"Zhou","year":"2001","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2022.105154_bib49","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/10408440591007313","article-title":"Mode of action: developmental thyroid hormone insufficiency \u2013 neurological abnormalities resulting from exposure to propylthiouracil","volume":"35","author":"Zoeller","year":"2005","journal-title":"Crit. Rev. Toxicol."},{"issue":"1","key":"10.1016\/j.yrtph.2022.105154_bib50","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/toxsci\/kfn225","article-title":"The effects of triclosan on puberty and thyroid hormones in male Wistar rats","volume":"107","author":"Zorrilla","year":"2009","journal-title":"Toxicol. Sci."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230022000411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230022000411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:32:40Z","timestamp":1759494760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230022000411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":49,"alternative-id":["S0273230022000411"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2022.105154","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isoflucypram: Combining in vivo and NAMs data in a weight of evidence approach to demonstrate the human non-relevance of the mode of action leading to the subtle thyroid effects observed in the rat","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2022.105154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105154"}}